Brighter has qualified to the top 10 in the Healthtech Unicorn Battle Europe
Brighter was nominated to the Healthtech Unicorn Battle Europe and, as a result, has qualified as one of the carefully selected top rated companies that are given the opportunity to pitch their idea live in the contest. The submission relates primarily to Brighter’s pioneering diabetes offering, Actiste® Diabetes Management as a Service.
“We are very proud to be one of the few selected companies. It confirms that Brighter is on the right track with our aim and mission, and we are ready to make an impact,” says Henrik Norström, CEO Brighter.
Date and time: November 10, 2020, 3 pm CET.
During the process, due to the nature of the event, Brighter was required to specify a range of capital desired (minimum USD 5 million to a maximum USD 30 million). This does not reflect or correspond to Brighter’s actual capital needs but was rather submitted for technical reasons.
About the event
The Healthtech Unicorn Battle Europe is part of the World Largest Startup Pitch Contest, where famous international VCs meet extraordinary startups from all over the world. The event is widely broadcasted throughout the world via social media channels and their partner’s network. The audience of 125k people from 67 countries will be watching, and the winner of the Healthtech Unicorn Battle Europe will be presenting the region in the Unicorn Cup Finals.
Further information about the event is available here: https://battle.startup.network/events/421968/.
For further information, please contact:
Investor Relations
IR@brighter.se
Henrik Norström, CEO Brighter
+46 733 40 30 45
henrik.norstrom@brighter.se
Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.